Ordering
Available Variants5 mg
CHA.63153-5mg
Price
€82.40
Available – Dispatch in 14 days
25 mg
CHA.63153-25mg
Price
€247.52
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.63153-5mg | €82.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.63153-25mg | €247.52 |
≥98% (HPLC), EBP-dpendent cholesterol synthesis inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C18H28N2O3S · HCl |
|---|---|
| CAS Number | 1678515-13-3 |
| Molecular Weight | 388.95 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Storage condition | desiccated, protect from light |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
TASIN-1 hydrochloride, with a CAS number of 792927-06-1, is a synthetic compound that has garnered significant attention in the scientific community due to its potential therapeutic applications. As a small molecule inhibitor, TASIN-1 hydrochloride has been shown to exhibit promising activity in modulating various cellular signaling pathways, particularly those involved in cancer progression and metastasis. Its mechanism of action involves the selective inhibition of specific protein-protein interactions, leading to the disruption of key signaling cascades that promote tumor growth and survival. Further research is warranted to fully elucidate the pharmacological properties and potential clinical utility of TASIN-1 hydrochloride, but preliminary studies suggest that it may represent a valuable lead compound for the development of novel cancer therapies. Additional investigations are needed to explore its efficacy and safety profile in preclinical models.
